Product Reports Resources Pricing Login Book a demo

HistoSonics

Health Tech & Medtech · Minneapolis, United States · Founded 2009

HistoSonics is pioneering a non-invasive, robotically assisted platform that utilizes focused sound energy to mechanically destroy diseased tissue at a sub-cellular level. The company operates in the medical technology sector, primarily serving healthcare providers and patients. HistoSonics' core technology, known as histotripsy, offers a non-ionizing and non-thermal treatment option, making it a safer alternative to traditional methods. The business model revolves around the development and commercialization of its proprietary platform, Edison™, which provides real-time treatment monitoring and procedural control. Revenue is generated through the sale of the Edison™ platform and associated services, including clinical trials and ongoing support. HistoSonics is currently conducting clinical trials in the United States and Europe under the HOPE4LIVER initiative, aiming to bring this innovative treatment to a broader market. Keywords: histotripsy, non-invasive, robotically assisted, focused sound energy, sub-cellular, medical technology, Edison™, clinical trials, HOPE4LIVER, real-time monitoring.

Valuation $2.5–5B
Revenue $100–500M
Headcount 100–500
Total funding $500M–1B
Unlock exact values This page shows ranges. Dealroom has the exact numbers for HistoSonics and the history behind them.
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Featured in
News HistoSonics raises growth equity at $3.75B valuation, backed by Reed Jobs' Yosemite Jun 22, 2026 News Petal Surgical adds more funding for incisionless surgical robot Jun 2, 2026

Investors

26 investors on HistoSonics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage
Venture Investors Health Fund
Fletcher Spaght, Inc.
Hatteras Venture Partners
TGap Ventures
Fletcher Spaght Ventures
Early Stage Partners
UM-MINTS
Series B+ 19 investors entered at this stage
Grand Rapids Business Journal
Grand Angels
Capital Community Angel Investors
HistoSonics
Varian Medical Systems
Johnson & Johnson Innovation
Lumira Ventures
State of Wisconsin Investment Board
Yonjin Venture
Signature Bank
Alpha Wave Global
HealthQuest Capital
Amzak Health
Wellington Management
Thiel Bio
K5 Global
Bezos Expeditions
Yosemite
Reed Jobs

Global footprint

Where HistoSonics has talent and traffic

Workforce by country
8 countries with
team presence
🇺🇸 United States95.6%
🇷🇸 Serbia1.9%
🇪🇸 Spain0.6%
🇸🇬 Singapore0.6%
🇦🇪 United Arab Emirates0.3%
Top 5 of 8 shown
Web traffic by country
13K monthly visits
across markets
🇺🇸 United States53.1%
🇨🇦 Canada21.5%
🇬🇧 United Kingdom13.8%
🇮🇳 India4.6%
🇭🇰 Hong Kong3.8%
Top 5 markets shown

Talent graph

The shape of HistoSonics's talent

Dealroom maps HistoSonics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

8 standout operatorsDealroom-flagged across the org
1 AI specialistincl. 1 core researchers
429 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock HistoSonics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$19M patent portfolio · 36 active families

Estimated portfolio value
$19M
0.50% of valuation · 2.6× larger than top peer Eight Sleep ($7M)
36 active patent families
Where HistoSonics innovates AcousticsBiomedical engineeringHistotripsyMedical physicsMinimal invasiv

Where HistoSonics concentrates vs peers

Each axis is a top-10 topic across HistoSonics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about HistoSonics

An AI-synthesized read of the highest-engagement posts about HistoSonics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See HistoSonics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles